BioSpace

6 immunology targets to sustain a mammoth I&I market

Johnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and Sanofi and Regeneron’s Dupixent.

作者 BioSpace

1 分钟阅读
6 immunology targets to sustain a mammoth I&I market
6 immunology targets to sustain a mammoth I&I market

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察